CardiovascularPeer Reviewed
Songling Xuemaikang capsule for grade 1 hypertension at low-to-moderate risk: a multicenter randomized placebo-controlled trial.
Authors (15)
Yuerong JiangXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Hua QuXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Haiyan GuoXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Ming GuoXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Phytomedicine : international journal of phytotherapy and phytopharmacology
Unknown
Published
Oct 13, 2025
Abstract
Abstract not available - data parsing issue resolved
Keywords
Ambulatory blood pressureGrade 1 hypertensionLow-to-moderate cardiovascular riskSongling xuemaikang
Article Metrics
Sourcepubmed
Related Research
Explore more articles in this research category to discover related studies and findings.